Press Release dated

RadNet Reports Record Third

Quarter Financial Results and Adjusts Upwards 2014 Guidance Ranges for Revenue and Adjusted EBITDA(1)

California, November 6, 2014 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing

high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 263 owned and/or operated

outpatient imaging centers, today reported financial results for its third quarter of 2014.

Dr. Howard Berger, President and Chief

Executive Officer of RadNet, commented, "We are very pleased with our performance in the third quarter. We reported record

quarterly Revenue, Adjusted EBITDA(1) and Net Income, all of which were substantial increases from last year's

third quarter. Benefits from our $30 million annualized cost savings program along with meaningful improvements in aggregate and

same center procedural volumes drove this financial performance."

Dr. Berger continued, "We continue

to experience strong volumes from new patients enrolled in state and privately managed healthcare exchanges as part of the Affordable

Care Act. Additionally, contribution from the small tuck-in acquisitions we recently completed and new capitation contracts we

have begun servicing are also partially driving our improving top line performance. On the expense side, we incurred some additional

costs during the quarter from the ramp-up of several newly acquired facilities, increased staffing and training of call center

and front office personnel at certain California locations addressing greater patient volumes and from the continued implementation

of our eRAD information technology solutions to several of RadNet's regional operations. These additional costs were partially

mitigated by our continued execution on $10 million of annualized additional cost savings we identified and announced several

"In addition to the growth we are

driving in our core imaging center business, we are continuing to pursue other avenues of expansion in newer initiatives such

as the sale and licensing of our eRAD suite of information technology solutions, the provision of inpatient and outsourced professional

radiology and management services and the establishment of joint ventures with hospitals and health systems. The traction we are

experiencing with these newer lines of business gives me confidence that these initiatives will become more significant drivers

of growth and future business opportunities," added Dr. Berger.

Third Quarter Financial Results

For the third quarter of 2014, RadNet

reported Revenue of $184.1 million, Adjusted EBITDA(1) of $33.4 million and Net Income of $4.5 million, respectively.

Revenue increased $8.9 million (or 5.1%), Adjusted EBITDA(1) increased $8.0 million (or 31.7%) and Net Income

increased $4.9 million, respectively, over the third quarter of 2013. Per share Net Income for the

third quarter was $0.10, compared to per share Net Loss in the third quarter of 2013 of $(0.01) (based upon a weighted average

number of diluted shares outstanding of 44.0 million and 39.2 million for these periods in 2014 and 2013, respectively).

Income in the third quarter of 2014 were certain non-cash expenses and non-recurring items including: $433,000 of non-cash employee

stock compensation expense resulting from the vesting of certain options and restricted stock; $112,000 of severance paid

in connection with headcount reductions related to cost savings initiatives; $1.3 million loss on the sale and disposal of equipment

and tenant improvements; and $1.3 million of combined non-cash amortization and write-off of Deferred

Financing Expense and discount on issuance and refinance of debt related to financing fees paid as part of our existing credit

For the third quarter of 2014, as compared

to the prior year's third quarter, MRI volume increased 8.0%, CT volume increased 11.9% and PET/CT volume increased 0.8%.

Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased

9.2% over the prior year's third quarter. On a same-center basis, including only those centers which were part of RadNet

for both the third quarters of 2014 and 2013, MRI volume increased 5.6%, CT volume increased 10.3% and PET/CT volume decreased

1.6%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other

exams, increased 6.3% over the prior year's same quarter.

Nine Month Financial Results

For the nine months ended September 30,

2014, RadNet reported Revenue, Adjusted EBITDA(1) and Net Income of $532.0 million, $94.5 million and $8.6 million

(excluding the tax adjusted losses on extinguishment of debt and sale and disposal of equipment), respectively. Revenue increased

$7.4 million (or 1.4%), Adjusted EBITDA(1) increased $13.5 million (or 16.7%) and Net Income increased $6.9 million

(also excluding the tax adjusted losses on extinguishment of debt and sale and disposal of equipment), respectively, over the

first nine months of 2013. Net Income for the nine month period ended September 30, 2014 was $0.20

per diluted share (excluding the tax adjusted losses on extinguishment of debt and sale and disposal of equipment),

compared to Net Income of $0.04 per diluted share in corresponding nine month period of 2013 (based upon a weighted average number

of fully diluted shares outstanding of 40.7 million and 39.9 million for these periods in 2014 and 2013, respectively).

Income in the nine months ended September 30, 2014 were certain non-cash expenses and non-recurring

items including: $2.1 million of non-cash employee stock compensation expense resulting from the vesting of certain options and

restricted stock; $976,000 of severance paid in connection with headcount reductions related to cost savings initiatives;

$1.6 million loss on the sale of certain capital equipment; $4.4 million of combined non-cash amortization

and write-off of Deferred Financing Expense and discount on issuance and refinance of debt related to financing fees paid as part

of our existing credit facilities; and $15.9 million loss on the extinguishment of debt related to the Company's March 25,

2014 refinancing of its senior unsecured notes with a new second lien term loan.

2014 Guidance Update

RadNet updates the previously announced 2014 fiscal year guidance

Dr. Berger highlighted, "Based upon

the strong third quarter results along with continuing confidence we have about the remainder of 2014, we have increased our Revenue

and Adjusted EBITDA(1) guidance levels for 2014 from the original guidance levels set at the beginning of the year

as well as from the increased levels we set after each of the first and second quarters. We continue to experience strong volumes,

particularly on the West Coast where there has been a disproportionately high participation in the state run and privately managed

healthcare exchanges. In response to this, we increased our capital spending to provide additional capacity and access, and to

accommodate further expected patients from the Affordable Care Act open enrollment, which begins on November 15th.

It was recently estimated by the Los Angeles Times that in California, within its Covered California insurance exchange, participation

is expected to increase from the current 1.2 million enrollees to 1.7 million enrollees after open enrollment."

Conference Call for Today

Dr. Howard Berger, President and Chief

Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss

its third quarter 2014 results on Thursday, November 6th, 2014 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Conference Call Details:

Date: Thursday, November 6, 2014

Time: 10:30 a.m. Eastern Time

Dial In-Number: 800-306-6784

International Dial-In Number: 913-312-1378

It is recommended that participants dial

in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts

available at http://public.viavid.com/index.php?id=111721 or http://www.radnet.com under the

"About RadNet" menu section and "News & Press Releases" sub-menu of the website. An archived replay

of the call will also be available and can be accessed by dialing 877-870-5176 from the U.S., or 858-384-5517 for international

callers, and using the passcode 8962332.

Regulation G: GAAP and Non-GAAP

Financial Information

This release contains certain financial

information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results.

The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based

performance. The Company believes this information is useful to investors and other interested parties because it removes unusual

and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition

against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with

GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not

be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation

of this information to the most comparable GAAP measures is included in this release in the tables which follow.

RadNet, Inc. is a national market leader

providing high-quality, cost-effective diagnostic imaging services through a network of 263 fully-owned and operated outpatient